This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Analyst Reports for AMD, Abbott Laboratories & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).
Markets Await Empire State Manufacturing Report
by Zacks Equity Research
Markets Await Empire State Manufacturing Report
Markets Closed in Remembrance of Dr. King
by Mark Vickery
Even though we're only just half way through the month, the lion's share of economic reports -- non-earnings-season-related -- have already happened for January.
Will Morgan Stanley (MS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Morgan Stanley (MS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Will Bank ETFs Perform in Light of Q4 Earnings?
by Sanghamitra Saha
Chances of a broad-based earnings beat are low-to-moderate as several stocks are experiencing a negative ESP.
Morgan Stanley (MS) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of Morgan Stanley (MS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Morgan Stanley (MS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Earnings Preview: Morgan Stanley (MS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Morgan Stanley (MS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Weak Loan Growth, IB to Hurt Morgan Stanley's (MS) Q4 Earnings
by Zacks Equity Research
Morgan Stanley's (MS) fourth-quarter earnings are expected to have been negatively impacted by a muted IB business performance.
Morgan Stanley (MS) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Morgan Stanley (MS) closed the most recent trading day at $93.51, moving +0.29% from the previous trading session.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
Citigroup (C) to Establish Investment Banking Unit in China
by Zacks Equity Research
Citigroup (C) plans to establish a wholly owned investment banking unit in China within a year, expanding its operations in the world's second-largest economy. The unit will initially have 30 employees.
Morgan Stanley (MS) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Morgan Stanley (MS) closed at $93.90 in the latest trading session, marking a +0.7% move from the prior day.
LPL Financial (LPLA) to Settle FINRA Claims, Agrees to Pay $6M
by Zacks Equity Research
LPL Financial (LPLA) agrees to pay more than $6 million in penalties to settle FINRA claims on securities violations.
Morgan Stanley (MS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Morgan Stanley (MS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Morgan Stanley (MS) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Morgan Stanley (MS) stood at $93.66, denoting a +0.88% change from the preceding trading day.
Morgan Stanley (MS) to See Record Japan Income as Trading Revives
by Zacks Equity Research
Morgan Stanley (MS) expects record revenues from Japan on the back of the country's debt and rates market trading resurgence.
BlackRock (BLK) Sued for Allegedly Misleading ESG Strategy
by Zacks Equity Research
BlackRock (BLK) faces a lawsuit by the U.S. state of Tennessee for violating consumer protection laws by misusing ESG factors in its investment strategy.
Morgan Stanley (MS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) reachead $90.76 at the closing of the latest trading day, reflecting a -0.9% change compared to its last close.
Morgan Stanley (MS) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Morgan Stanley (MS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The Zacks Analyst Blog Highlights Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources
by Zacks Equity Research
Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources are part of the Zacks top Analyst Blog.
Top Analyst Reports for Adobe, AstraZeneca & Intel
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), AstraZeneca PLC (AZN) and Intel Corporation (INTC).
Morgan Stanley (MS) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Morgan Stanley (MS) stood at $82.82, denoting a +0.66% change from the preceding trading day.
Investors Heavily Search Morgan Stanley (MS): Here is What You Need to Know
by Zacks Equity Research
Morgan Stanley (MS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why the Market Dipped But Morgan Stanley (MS) Gained Today
by Zacks Equity Research
Morgan Stanley (MS) concluded the recent trading session at $81.21, signifying a +0.4% move from its prior day's close.